Amyris Partners with Queensland on Biofutures Acceleration Program in Next Step Toward Planned Development of Biorefinery
June 20 2017 - 08:30AM
Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and
the Government of Queensland, Australia today announced the next
step their plans to develop a leading industrial biotechnology hub
in Southeast Asia. Plans call for developing a new production plant
with support from local partners to produce Amyris’s sugar
cane-based ingredient called farnesene, which is used in products
including cosmetic emollients, fragrances, nutraceuticals,
polymers, and lubricants.
Acceleration of this project, which was first announced on
December 6, 2016, came out of the Queensland Government’s
Biofutures Acceleration Program that offers support to companies to
build commercial-scale biorefineries in regional Queensland. Amyris
was chosen based on its legacy expertise in operating such
production facilities.
Queensland Premier Annastacia Palaszczuk said the interest by
Amyris was welcome.
“Amyris is seeking to replicate its successful biorefinery in
Brazil and sees Queensland as an ideal location due to the
abundance of sugarcane and close proximity to Asia,” Ms Palaszczuk
said.
“The company’s proposed biorefinery would aim to produce 23,000
tonnes a year of a sugar cane-based ingredient called farnesene
which is used in a range products including cosmetics, fragrances,
nutraceuticals, polymers, and lubricants.”
“The Queensland Government’s funding and support for biorefinery
projects will create high-value jobs and investment in regional
Queensland by using renewable feedstocks to create biofuel and
other bioproducts.”
“We are very pleased with the commitment of the Queensland
Government to be leaders of the Bioeconomy,” said John Melo, Amyris
President & CEO. “Our growing demand in China for Vitamins
and the Asian demand for cosmetics and fragrances supports a new
specialty farnesene fermentation factory in Queensland. The funding
from the Queensland government along with the operating expertise
and sugar cane base of our local partner make this factory possible
and enable savings from our current production in Brazil and the
associated shipping costs. Like all our new projects, this factory
is expected to be sold out when it starts operating with agreements
to supply our current partners in China and other Asian markets.
Queensland offers an excellent location option for Amyris with its
favorable business climate, extensive sugar industry and geographic
proximity to these markets.”
Amyris and the Government of Queensland have successfully
partnered on a number of initiatives since 2010 designed to foster
adoption of renewable product solutions targeting large global
markets while also supporting the development of a Queensland-based
biotechnology industry using feedstock from local sugarcane.
About Amyris
Amyris is the integrated renewable products company that is
enabling the world’s leading brands to achieve sustainable growth.
Amyris applies its innovative bioscience solutions to convert plant
sugars into hydrocarbon molecules and produce specialty ingredients
and consumer products. The company is delivering its No Compromise®
products across a number of markets, including specialty and
performance chemicals, flavors and fragrances, cosmetics
ingredients, pharmaceuticals, and nutraceuticals. More information
about the company is available at www.amyris.com.
Forward-Looking Statements
This release contains forward-looking statements, and any
statements other than statements of historical facts could be
deemed to be forward-looking statements. These forward-looking
statements include, among other things, statements regarding future
events (such as the expected development of a leading industrial
biotechnology hub in Southeast Asia, including a new production
plant, the anticipated demand in Asia for Amyris products, expected
cost savings from the planned production facility relative to
Amyris’s current production in Brazil, and the anticipated demand
for production at such facility) that involve risks and
uncertainties. These statements are based on management's current
expectations and actual results and future events may differ
materially due to risks and uncertainties, including risks related
to manufacturing capacity at Amyris’s Brotas facility, delays or
failures in development, production and commercialization of
products, liquidity and ability to fund capital expenditures,
Amyris’s reliance on third parties to achieve its goals, and other
risks detailed in the “Risk Factors” section of Amyris’s quarterly
report on Form 10-Q filed on May 15, 2017. Amyris disclaims any
obligation to update information contained in these forward-looking
statements whether as a result of new information, future events,
or otherwise.
Amyris, the Amyris logo and No Compromise are registered
trademarks of Amyris, Inc. All other trademarks are trademarks of
their respective owners.
Note to Editors: Please see news release issued December 6,
2016, entitled, "Amyris Partners with Queensland to Create the
Leading Industrial Biotechnology Hub in Southeast Asia".
Contacts:
Kerryn Manifold
Queensland Government
Deputy Director - Government Media Unit
+61 424 510973
premiers.media@ministerial.qld.gov.au
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
investor@Amyris.com
pr@Amyris.com
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From Mar 2023 to Mar 2024